Search the Newsreel

Corporacion Inmobiliaria Vesta, S.A.B de C.V. Revenue Breakdown – BOATS:VTMX

This article provides a revenue breakdown for Corporacion Inmobiliaria Vesta, S.A.B de C.V. (VTMX). Last year, the company generated $259.20 million USD, with its top-performing segment, Rents, contributing $259.17 million USD. Mexico was the largest contributor by country, accounting for $283.22 million USD.

Press Releases about Mobility Global Inc. Common Stock (NYSE:MBGL)

This article compiles recent press releases concerning Mobility Global Inc. (NYSE: MBGL). Key announcements include the company's Q2 2026 financial results, upcoming participation in investor conferences, and the previous notification regarding the release of these financial results. The stock's last price was $20.34, showing …

Intellicheck (NASDAQ:IDN) Downgraded to "Hold" Rating by Wall Street Zen

Wall Street Zen downgraded Intellicheck (NASDAQ:IDN) from "buy" to "hold," causing the stock to drop 25.1% to $2.81, near its 12-month low. Despite the downgrade and similar actions by other analysts, the consensus remains a "Moderate Buy" with an average target price of $6.50. …

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News

The article provides information related to Parabilis Medicines (PBLS) stock options chain, including quotes and news. The content itself is not available in the provided input.

Tidewater Renewables (TSX:LCFS) Stock Price Faces Earnings Quality Questions

Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ

Intellicheck Q2 Earnings Call Highlights

Intellicheck (IDN) reported Q2 revenue of $5.9 million and net income of $633,000. However, the company faces uncertainty due to a major customer's vendor-resiliency review, which could modestly pressure full-year revenue if the customer proceeds with its plan. Despite this, Intellicheck achieved its fifth …

ARD BILISIM TEKNOLOJILERI (ARDYZ) Hisse Senedi

Mobility Global Inc (MBGL)

Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership

ARCH Venture Fund XII and related entities have disclosed a 5.3% beneficial ownership stake in Parabilis Medicines (PBLS), amounting to 6,412,780 shares of common stock. This Schedule 13G filing indicates a passive investment, with ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, …

Corporacion Inmobiliaria Vesta (NYSE:VTMX) Insider Sells $34,800.00 in Stock

DA Davidson cuts Intellicheck stock price target on customer risk

DA Davidson has reduced its price target for Intellicheck (NASDAQ:IDN) from $7.50 to $5.00, while maintaining a Buy rating. This decision comes despite strong Q2 results, including accelerated SaaS revenue growth and increased Adjusted EBITDA margin, due to the company's largest customer (accounting for …

Vesta: Undervalued In The Long-Term With Sights On Portfolio Growth (NYSE:VTMX)

Corporación Inmobiliaria Vesta (VTMX) is considered undervalued with a significant upside potential of 245.73% by 2030, driven by its expanding industrial portfolio and projected rental income growth. While the company's FFO per share is expected to increase substantially due to nearshoring and portfolio expansion, …

DA Davidson Lowers Intellicheck (NASDAQ:IDN) Price Target to $5.00

DA Davidson lowered its price target for Intellicheck (NASDAQ:IDN) to $5.00 from $7.50, but maintained a "buy" rating, indicating a potential upside of over 80%. This adjustment comes despite Intellicheck reporting quarterly EPS of $0.03, matching expectations, on $5.94 million in revenue, and the …

Mobility Global (NYSE:MBGL) Shares Gap Up After Insider Buying Activity

Mobility Global (NYSE:MBGL) shares gapped up after Director Mark S. Peek purchased 50,000 shares over three days for a total of approximately $980,550. The stock opened at $20.82, up from its previous close of $19.83. Analysts maintain a "Moderate Buy" rating with a consensus …

T. Rowe Price Associates (VRRM) reports 241,697 Verra Mobility shares in 13G/A

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G/A, reporting beneficial ownership of 241,697 shares of Verra Mobility Corp. common stock. This holding represents 0.2% of Verra Mobility's outstanding common stock. T. Rowe Price Associates maintains sole voting and dispositive power over …

Tencent Holdings (BILI) discloses 40M-share beneficial stake in Bilibili

Tencent Holdings Limited has disclosed a beneficial ownership of 40,014,008 Class Z Ordinary Shares in Bilibili Inc., representing 11.8% of the outstanding shares. This stake includes holdings by its subsidiaries Tencent Mobility Limited, Huang River Investment Limited, and China Literature Limited. Tencent Mobility Limited …

Akfen Yenilenebilir Enerji (AKFYE) için bilanço sonrası hedef fiyat açıklandı

Intellicheck (IDN) Q2 2026 Earnings Call: Major Customer Review Shapes Outlook

Intellicheck reported strong Q2 2026 results with $5.9 million in revenue, a 16% year-over-year increase, and a 91% gross margin, achieving its fifth consecutive quarter of positive adjusted EBITDA. Despite this performance, a significant customer accounting for 29% of first-half revenue is evaluating a …

BILICI YATIRIM (BLCYT) Hisse Senedi

Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal

Parabilis Medicines, Inc. reported its Q2 2026 results, showing a significant increase in cash and cash equivalents to over $1.1 billion. This boost follows its June 2026 IPO, which generated $787.9 million in net proceeds, and a $50.0 million upfront payment from its collaboration …

Parabilis Medicines (PBLS) Earnings Date and Reports 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com

The article is a brief financial news item from Investing.com, reporting on a Form 8K filing by Parabilis Medicines for August 13th. It provides no further details beyond stating the filing occurred on that date.

Earnings Flash (PBLS) Parabilis Medicines, Inc. Reports Q2 Revenue $148,000

Parabilis Medicines, Inc. (PBLS) reported its Q2 revenue as $148,000. The company, a clinical-stage biopharmaceutical firm, focuses on developing transformative medicines for "undruggable" protein targets using its proprietary Helicon platform. Analysts currently have a "BUY" consensus for PBLS with an average target price of …

Mobilicom Q2 Earnings Call Highlights

Intellicheck expects GAAP profitability in 2026 as a 29% revenue customer evaluates a multi-vendor IDV approach

Earnings Call Insights: Intellicheck (IDN) Q2 2026 MANAGEMENT VIEW * Bryan Lewis (President, CEO & Director) said the company’s diversification strategy “continues to produce results,” citing “4 consecutive quarters of profitability,” while flagging a customer concentration event: “A customer that represents about 29% of …

Earnings call transcript: Mobilicom rises on q2 delivery ramp and defense wins

Mobilicom Limited reported a sequential rise in Q2 2026 revenue to approximately $1.2 million, driven by monthly deliveries under a U.S. defense program. This shift contributed to a 9.22% increase in its stock after hours, despite a regular session decline. The company highlighted strong …

Mobility Global (NYSE:MBGL) Director Mark Peek Purchases 25,000 Shares of Stock

Mobility Global Director Mark Peek recently purchased 25,000 shares of the company's stock for $487,500, significantly increasing his direct holdings. The company also announced a quarterly dividend of $0.06 per share, providing a 1.2% annual yield, and reported quarterly EPS of $0.18 on $468 …

Mobilicom Reports H1 2026 Results: Full Earnings Call Transcript

Earnings call transcript: Intellicheck Q2 2026 revenue edges past forecasts

Intellicheck reported Q2 2026 earnings matching forecasts and revenue slightly above expectations, but the stock dropped 16% after hours due to uncertainty surrounding a major customer's vendor evaluation. Despite strong sequential and year-over-year revenue growth and consistent profitability, investors focused on the potential impact …

Intellicheck Mobilisa earnings matched, revenue topped estimates

Mobility Global Director Purchased Shares Worth Over $980K

Mark S. Peek, a Director at Mobility Global (MBGL), purchased 50,000 shares of common stock in three transactions between August 11-13, 2026. The total purchase amounted to $980,566, with share prices ranging from $19.49 to $19.8714. Following these transactions, Peek directly owns 50,000 shares …

Mobility Global Inc. (MBGL) director purchases 50,000 shares in open‑market buys

Mobility Global Inc. director Mark S. Peek reported open-market purchases of 50,000 shares of common stock over three days in August 2026. The purchases were made on August 11, 12, and 13 at prices ranging from $19.49 to $19.87 per share. These transactions, detailed …